Cipla Vs Dr. Reddy’s: Which pharma giant offers better risk-reward as spotlight shifts to US pipeline
- Posted on July 29, 2026
- By Financial Express
- 0 Views
- 1 min read
In brief
Generating AI summary…
Cipla Vs Dr. Reddy’s: Which pharma giant offers better risk-reward as spotlight shifts to US pipeline
Cipla and Dr. Reddy's entered FY27 on different trajectories. While Cipla posted record quarterly revenue backed by respiratory growth, Dr. Reddy's is betting on semaglutide recovery and biosimilars to drive its next phase of growth.
